AstraZeneca PLC vs Intel Corporation
Market cap comparison over time
AstraZeneca PLC
$285.4B
Rank #45
Intel Corporation
$294.8B
Rank #41
Market Cap Over Time
Key Moments
- AstraZeneca PLC overtook Intel Corporation by 2022
- Intel Corporation overtook AstraZeneca PLC by 2023
- AstraZeneca PLC overtook Intel Corporation by 2024
- Intel Corporation overtook AstraZeneca PLC by 2026
Year-by-Year Comparison
| Year | AstraZeneca PLC | Intel Corporation | Leader |
|---|---|---|---|
| 2026 | $285.4B | $294.8B | Intel Corporation |
| 2025 | $282.2B | $185.5B | AstraZeneca PLC |
| 2024 | $196.9B | $100.8B | AstraZeneca PLC |
| 2023 | $198.1B | $249.2B | Intel Corporation |
| 2022 | $195.3B | $128.1B | AstraZeneca PLC |
| 2021 | $163.9B | $240.1B | Intel Corporation |
| 2020 | $136.9B | $226.4B | Intel Corporation |
| 2019 | $132.8B | $265.3B | Intel Corporation |
| 2018 | $97.9B | $203.0B | Intel Corporation |
| 2017 | $85.9B | $194.8B | Intel Corporation |
| 2016 | $64.5B | $148.8B | Intel Corporation |
| 2015 | $76.6B | $136.8B | Intel Corporation |
| 2014 | $76.2B | $139.9B | Intel Corporation |
| 2013 | $61.7B | $97.0B | Intel Corporation |
| 2012 | $46.3B | $74.1B | Intel Corporation |
| 2011 | $42.7B | $84.2B | Intel Corporation |
| 2010 | $40.3B | $70.5B | Intel Corporation |
| 2009 | $38.9B | $66.4B | Intel Corporation |
| 2008 | $32.3B | $46.1B | Intel Corporation |
| 2007 | $32.3B | $81.7B | Intel Corporation |
| 2006 | $39.1B | $60.8B | Intel Corporation |
| 2005 | $34.5B | $73.5B | Intel Corporation |
| 2004 | $25.2B | $68.0B | Intel Corporation |
| 2003 | $32.9B | $92.5B | Intel Corporation |
| 2002 | $23.4B | $44.8B | Intel Corporation |
| 2001 | $30.5B | $90.1B | Intel Corporation |
| 2000 | $33.1B | $85.9B | Intel Corporation |
| 1999 | $25.7B | $117.5B | Intel Corporation |
| 1998 | $27.2B | $84.5B | Intel Corporation |
| 1997 | $21.4B | $50.0B | Intel Corporation |
| 1996 | $16.3B | $46.5B | Intel Corporation |
| 1995 | $11.1B | $20.1B | Intel Corporation |
| 1994 | $7.5B | $11.3B | Intel Corporation |